Characterization of rpoB mutations in rifampin-resistant isolates of Mycobacterium tuberculosis cultured from the Iranian patients

Doustdar, Farahnoush; Khosravi , Azardokht; Farnia , Parisa; Bahremand, AhmadReza

year 1, Issue 1 (Spring 2007) Iran J Med Microbiol 2007, 1(1): 17-22 | Back to browse issues page

Mendeley

Zotero

RefWorks

Doustdar F, Khosravi A, Farnia P, Bahremand A. Characterization of rpoB mutations in rifampin-resistant isolates of Mycobacterium tuberculosis cultured from the Iranian patients. Iran J Med Microbiol 2007; 1 (1) :17-22
URL: http://ijmm.ir/article-1-69-en.html

Characterization of rpoB mutations in rifampin-resistant isolates of Mycobacterium tuberculosis cultured from the Iranian patients

Farahnoush Doustdar

¹, Azardokht Khosravi²

, Parisa Farnia³

, AhmadReza Bahremand⁴

1- Dept. of Microbiology, School of Medicine, Ahwaz Jundishapour University of Medical Sciences, Ahwaz, Iran , f_doustdar@yahoo.com
2- Dept. of Microbiology, School of Medicine, Ahwaz Jundishapour University of Medical Sciences, Ahwaz, Iran
3- Iranian National Reference TB laboratory, National Research Institute of Tuberculosis and Lung Disease (NRITLD), WHO Collaborating Centre of Tuberculosis, Tehran, Iran
4- Dept. of Mycobacteriology, Iran Pasteur institute.

Abstract: (15470 Views)

Background and objectives: In this project we investigated the frequency of mutations within the rifampin resistance-determining region (RRDR) of rpoB gene to determine whether this region is useful for molecular detection of rifampin resistant isolates of Mycobacterium tuberculosis from Iranian patients.
Material and Methods: A set of 25 rifampin resistant and 5 randomly chosen fully susceptible M. tuberculosis complex strains obtained from sputum samples of individual patients were investigated. The M. tuberculosis H37RvT and CDC 1551 standard strains were used as controls. Using the specific primers, the entire RRDR of rpoB gene of selected samples was amplified and sequenced directly.
Results: Genetic alterations in the RRDR were present among 96.0% of isolates. The majority of rifampin resistant isolates (72.0 %) showed missense mutations in the core region of rpoB that led to substitutions of amino acids at Ser-531 (60.0 %), His-526 (16.0 %) orAsp-516 (8.0 %). While the codon 531 has been the most common site of nucleotide substitutions worldwide, the frequencies of mutations at the codons 526 and 516 among the Iranian isolates were different from other geographical regions. Mutation at codon 533 was found at higher frequency (8%) comparing to the report from other countries. '
Conclusion:The high rate of mutations within the RRDR of the rpoB gene suggests that targeted screening of the RRDR may be feasible for the determination of rifampin resistance in clinical isolates of Mycobacterium tuberculosis from Iran.

Keywords: Mycobacterium tuberculosis, rifampin resistance, mutation

Full-Text [PDF 217 kb] (2911 Downloads)

Type of Study: Original Research Article | Subject: Molecular Epidemiology
Received: 2013/11/10 | Accepted: 2013/11/10 | ePublished: 2013/11/10

References

1. Marshall J, Chahin A, Rush B. Review of Clinical Databases. In: "MIT Critical Data, Secondary Analysis of Electronic Health Records" First Online: September 2016, Chapter 2. [DOI:10.1007/978-3-319-43742-2_2] [PMCID]

2. Debra Revere D, Hills RH, Dixon BE, Gibson PJ, Graniss SJ. Notifiable condition reporting practices: implications for public health agency participation in a health information exchange. BMC Public Health. 2017; 11; 17 (1):247. [DOI:10.1186/s12889-017-4156-4] [PMID] [PMCID]

3. Collen MF, Slack WV, Bleich HL. Medical Databases and Patient Record Systems. In The History of Medical Informatics in USA. Collen M, Ball M. 2017 Springer International Publishing AG..

4. Hajia M, Rahbar M, Farzami MR, Asl HM, Dolatyar A, Imani M, et al. Assessing clonal correlation of epidemic Vibrio cholerae isolates during 2011 in 16 provinces of Iran. Curr Microbiol. 2015;70(3):408-14. [DOI:10.1007/s00284-014-0725-2] [PMID]

5. Mafi M, Hajia M, Goya MM. A five years study on the epidemiological approaches of Cholera in Iran. Caspian J Inter Medicine. 2016; 7 (3), 162-167.

6. M Hajia, M Rahbar, F Fallah, N Safadel. Detection of Bordetella pertussis in infants suspected to have whooping cough. The Open Resp Med J. 2012; 6: 34-36. [DOI:10.2174/1874306401206010034] [PMID] [PMCID]

7. Khoo SH, Hajia M, Storey CC, Klapper PE, Wilkins EG, Denning DW, Dunbar EM, Corbitt G, Mandal BK. Influenza-like episodes in HIV-positive patients: the role of viral and'atypical'infections. AIDS (London, England). 1998 May;12(7):751-7.

8. Hajia M, Mohammad Rahbar M, Amini R. Is PCR assay reliable for diagnosis of extrapulmonary tuberculosis? African Journal of Microbiology Research. 2009; 3(12):877-881.

9. Dahim P, Amini R, Safadel N. Implementation of Quality Management System in Iranian. Medical Laboratories. Iran J Public Health. 2009; 38 (Suppl. 1):150-152.

10. Aisu S, Nyegenye W, Kiyaga C, Dfendu M, Sewanyana I , Namakula A (et al). Quality assurance as an integral component of diagnostic testing in clinical laboratories and point-of care testing: the Uganda experience: country profile. African Journal of Laboratory Medicine. 2016; 5(2):1-5. [DOI:10.4102/ajlm.v5i2.447] [PMID] [PMCID]

11. Ravaghi H, Khodayari Zarnaq R, Adel A, Badpa M, Adel M, Abolhassani N. A Survey on Clinical Governance Awareness Among Clinical Staff: A Cross-Sectional Study. Global Journal of Health Science. 2014; 6(6):37-42. [DOI:10.5539/gjhs.v6n6p37] [PMID] [PMCID]

12. Anjarani S, Safadel N, Dahim P. Amini R, Mahdavi S, Samiee S. Establishment of national laboratory standards in public and private hospital laboratories. Iranian J Public Health. 2013;42:96-101.

13. Safadel N, Anjarani S, Farzami MR, Amini R, Samiee SM, Dahim P. Establishing an Iranian medical laboratory standard based on ISO 15189. Accreditation and Quality Assurance. 2014;19(6): 473-476. [DOI:10.1007/s00769-014-1090-3]

14. Hajia M, Safadel N, Samiee SM, Dahim P, Anjarani S, Nafisi N, et al. Quality Assurance Program for Molecular Medicine Laboratories. Iran J Public Health. 2013; 42(Supple1): 119-124.

15. Grannis SJ. Electronic Laboratory Data Quality and the Value of a Health Information exchange to support public health reporting processes. AMIA Annu Symp Proc. 2011:322-330.

16. Hajia M. Uncertainty results of molecular diagnostic methods: Causes and Barriers.

17. Safadel N, Dahim P, Anjarani S, Rahnamaye Farzam Mi, Mirab Samiee S, Amini R, et al. Challenges of implementing Iranian national laboratory standards. Iranian J Public Health. 2013; 42:125-128.

18. Hajia M, Sohrabi A. Current situation and required future policy of molecular methods at Iranian diagnostic centers. Submitted Draft.

19. Abhyankar S, Demner-Fushman D, McDonald CJ. Standardizing clinical laboratory data for secondary use. Journal of Biomedical Informatics 2012; 45: 642-650. [DOI:10.1016/j.jbi.2012.04.012] [PMID] [PMCID]

20. Dixon BE, Siegel JA, Oemig T, Grannis S. Electronic Health Information Quality Challenges and Interventions to Improve Public Health Surveillance Data and Practice. Electronic Health Information Quality. 2013; 128:546-553. [DOI:10.1177/003335491312800614] [PMID] [PMCID]

21. Bean NH, Martin SM. Implementing a network for electronic surveillance reporting from public health reference laboratories: an international perspective. Emerg Infect Dis. 2001 Sep-Oct; 7(5):773-9. [DOI:10.3201/eid0705.010002] [PMID] [PMCID]

22. Jonnalagadda SR, Goyal P, Huffman MD. Automating data extraction in systematic reviews: a systematic review. Systematic Reviews. 2015; 4(78):1-16. [DOI:10.1186/s13643-015-0066-7] [PMID] [PMCID]

23. Dixon BE, Grannis SJ, Revere D. Measuring the impact of a health information exchange intervention on provider-based notifiable disease reporting using mixed methods: a study protocol. BMC Medical Informatics and Decision Making 2013, 13:121. [DOI:10.1186/1472-6947-13-121] [PMID] [PMCID]

24. Hajia M, Amirzargar A, Ghoreish M, Sam M. Estimation the frequency of human immunodeficiency virus among male and female patients, Iran. Cell Journal. 2012;13(4):237-242.

25. Hajia M, M RahbarM, Alikhani Y. Efficiency of PCR Method for Screening Pulmonary Tuberculosis Patients under DOTs Protocol Therapy. Iranian Journal of Public Health. 2005; 34(2):9-13.

26. Shafiei R, Mahmoodzadeh A, Hajia M, Sanati A, Shafiei F. Epidemiology of malaria in Khorasan Razavi province, northeast of Iran, within 7 years (April 2001-March 2008) Ann Trop Med Publ Health. 2011; 4(1):12-17. [DOI:10.4103/1755-6783.80515]

27. Rahbar M, Zahraei M, Omidvarnia A, Afshani MT, Glami M, Sabourian R, et al. Survey of epidemiology and bacteriology features of cholera in Iran. Asian Pac J Trop Med. 2010; 3(1):45-47. [DOI:10.1016/S1995-7645(10)60030-2]

28. Wadhwa V, Rai S, Thukral T. Laboratory quality management system: Road to accreditation and beyond. Indian J Med Microbiol. 2012; 30(2):131-140. [DOI:10.4103/0255-0857.96647] [PMID]

29. Gulley ML. Clinical Laboratory Reports in Molecular Pathology. Arch. Of Path & Lab Medicine. 2007:131 (6).

30. Silk BJ, Berkelman RL. A Review of Strategies for Enhancing the Completeness of Notifiable Disease Reporting. Journal of Public Health Management & Practice. 2005; 11: 191-200. [DOI:10.1097/00124784-200505000-00003]

31. Morse SS, Mazet JA, Woolhouse M, Parrish CR, Carroll D, Karesh WB, Zambrana-Torrelio C, Lipkin WI, Daszak P. Prediction and prevention of the next pandemic zoonosis. The Lancet. 2012 Dec 1;380(9857):1956-65. [DOI:10.1016/S0140-6736(12)61684-5]

32. Voldstedlund M, Haarh M, Mølbak K. The Danish microbiology database (MiBa) 2010 to 2013. Eurosurveillance. 2014; Jan 9;19(1):20667. [DOI:10.2807/1560-7917.ES2014.19.1.20667] [PMID]